Double-Blind Comparison of Bupropion Sustained Release and Sertraline in Depressed Outpatients
about
Serotonin and depression: a disconnect between the advertisements and the scientific literature.Sertraline versus other antidepressive agents for depressionSertraline versus other antidepressive agents for depressionSertraline versus other antidepressive agents for depressionBupropion: a systematic review and meta-analysis of effectiveness as an antidepressantThe other face of depression, reduced positive affect: the role of catecholamines in causation and cureThe Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder.Cocaine-associated stroke: three cases and rehabilitation considerations.Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis.Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women.The efficacy and tolerability of bupropion in the treatment of major depressive disorder.Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression.Bupropion: pharmacology and therapeutic applications.Bupropion: a review of its use in the management of major depressive disorder.Antidepressant-induced sexual dysfunction.Insomnia in patients with depression: some pathophysiological and treatment considerations.Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V.Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmissionDuloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.Effect of bupropion on sexual dysfunction.Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.Psychopharmacology in dermatology.How should primary care doctors select which antidepressants to administer?Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.Resolution of sleepiness and fatigue: a comparison of bupropion and selective serotonin reuptake inhibitors in subjects with major depressive disorder achieving remission at doses approved in the European Union.Bupropion-sustained release as a treatment for SSRI-induced sexual side effects.Evaluating changes in sexual functioning in depressed patients: sensitivity to change of the CSFQ.Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms.The effect of hetero- and homosexual experience and long-term treatment with fluoxetine on homosexual behavior in male rats.Sexual dysfunction and physicians' perception in medicated patients with major depression in Taiwan.The Selective Serotonin Reuptake Inhibitor Sertraline: Its Profile and Use in Psychiatric Disorders
P2860
Q21090148-D0E7E938-EA44-4875-9DBD-D6E88F0BA622Q24235928-AA3E5A7C-2AD6-47A7-829E-657CEFAA379DQ24241023-728757BC-925E-4349-831D-25F4790DAE89Q24241157-FBACFEC6-E5E3-490C-BE22-31DA0C79F1A7Q26747727-16910653-F569-4B21-8245-F40B36A71001Q28269179-402CB698-7AC8-44AD-A98F-07CF7CD4280FQ30278438-CA5EBF8E-DAF0-40A8-AD88-B68B3FFE0C47Q31379654-A3E414E1-4D1B-4D00-9D4B-5BA1295BBDDDQ33365152-B7418AFF-B56C-43F0-9054-DAF1F5BA9527Q33946901-D37686FA-543A-48AB-BF23-10B6F31AD95AQ34226014-065CA725-1BED-48D2-8E0E-137D048C1936Q34495752-63BD1950-0869-4E0F-88CD-8716E745FFDBQ34569990-C351EEE3-EB3D-462B-8642-E3E312982128Q34764861-98C86BAE-6A89-4942-9D90-04B94630140CQ34874381-21778591-7B7D-40D5-A3FA-935F0E4054A2Q34976344-368669F9-9CD9-4496-A948-C18A1CD8A902Q35549106-1F26059C-C3D0-4853-9624-A4B14F9936D3Q35680384-527AA921-4429-4771-A182-C7ECAA61A061Q36052518-EDCBADE1-93F0-4638-B74B-9052D7C96DFCQ36270312-2D38FBC4-7984-48F6-8E0D-6FFDCDAE0C9BQ36313107-F542D0D5-B19D-4F4F-A94D-57945AA45FE7Q36972675-4010AA0E-2A6D-4753-A67B-9E7060F60A8CQ37101756-E84304BF-3C6E-47A8-AAD5-1AC346B3CB42Q38014710-DE8E4D99-FB50-43DD-AD86-87FBB8A46A09Q43235413-84B82D98-A826-4AC8-99DC-FF5E268DE7C0Q43567081-36510F33-3469-46CD-B7B6-6C8220305B63Q43917932-DD0B9B13-9F29-462B-813A-B446408EF26DQ43917936-85475692-2577-4144-90C7-6150659B12F0Q44177213-82F1CB35-AAE1-4FB0-A1CB-5F31D3786671Q51782704-A0B83664-D1BB-4720-B833-84CD278A99FAQ51902782-8815259D-0B0F-468E-B9C6-65165E6977DFQ56016702-95409869-A1DD-4136-97D3-6BBB5E58DD7F
P2860
Double-Blind Comparison of Bupropion Sustained Release and Sertraline in Depressed Outpatients
description
article
@en
im Dezember 1997 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 1997
@uk
ലേഖനം
@ml
name
Double-Blind Comparison of Bup ...... aline in Depressed Outpatients
@en
Double-Blind Comparison of Bup ...... aline in Depressed Outpatients
@nl
type
label
Double-Blind Comparison of Bup ...... aline in Depressed Outpatients
@en
Double-Blind Comparison of Bup ...... aline in Depressed Outpatients
@nl
prefLabel
Double-Blind Comparison of Bup ...... aline in Depressed Outpatients
@en
Double-Blind Comparison of Bup ...... aline in Depressed Outpatients
@nl
P2093
P356
P1476
Double-Blind Comparison of Bup ...... aline in Depressed Outpatients
@en
P2093
Arlene R. Hughes
J. Andrew Johnston
John A. Ascher
R. Taylor Segraves
Richard J. Kavoussi
P304
P356
10.4088/JCP.V58N1204
P577
1997-12-15T00:00:00Z